Comparison

Teneligliptin European Partner

Item no. TMO-T37522-5mg
Manufacturer TargetMol
CASRN 760937-92-6
Amount 5 mg
Quantity options 100 mg 1 mL x 10 mM (in DMSO) 10 mg 1 mg 200 mg 25 mg 50 mg 5 mg
Category
Type Inhibitors
Specific against other
Smiles CC=1C=C(N(N1)C2=CC=CC=C2)N3CCN(CC3)[C@H]4C[C@@H](C(=O)N5CCSC5)NC4
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Alias MP513,MP-513
Shipping Condition Cool pack
Available
Manufacturer - Targets
DPP-4
Shipping Temperature
Cool pack
Storage Conditions
-20
Molecular Weight
426.58
Description
Teneligliptin (MP-513) is a novel dipeptidyl peptidase 4 (DPP IV) inhibitor for the treatment of type 2 diabetes mellitus with hypoglycemic activity for the study of obesity and diabetes.
Pathways
Proteases/Proteasome

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 5 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close